Natural Health Trends Earnings Call Transcripts
Fiscal Year 2025
-
Fourth quarter revenue grew 3% sequentially but fell 10% year-over-year, with gross margin impacted by inventory write-offs. Restructuring is nearly complete, with $1.5 million in annualized cost savings expected in 2026 and a continued focus on dividends and international growth.
-
Q3 2025 saw an 11% sales decline and a net loss, driven by economic headwinds and product timing. Restructuring aims for $1.5M in annual savings, with investments in technology and new products to support future growth.
-
Q2 2025 net sales declined 6% year-over-year to $9.8 million, with Hong Kong sales down 5%. Strategic supply chain shifts, new market launches, and disciplined expense management aim to offset economic and trade headwinds.
-
Q1 2025 revenue declined 2% year-over-year to $10.7 million, but orders rose 9% sequentially. Gross margin improved, operating loss narrowed, and a quarterly dividend was declared. The company is focused on mitigating tariff impacts and optimizing its supply chain.
Fiscal Year 2024
-
Fourth quarter 2024 revenue was flat year-over-year, with Greater China sales up 7% but declines in Taiwan and North America. Gross margin slipped slightly, and net income fell to $176,000. $9.2 million in dividends were paid for the year.
-
Q3 2024 revenue rose 1% year-over-year to $10.7 million, with improved operating results for three consecutive quarters. Gross margin declined due to higher product costs, while active members fell 11%. A $0.20 per share dividend was declared.
-
Q2 2024 net sales remained flat at $10.5 million, with improved profitability and strong performance in Taiwan and North America. New product launches and member engagement initiatives supported stability despite ongoing consumer spending challenges.